{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T06:10:11Z","timestamp":1770531011476,"version":"3.49.0"},"reference-count":30,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T00:00:00Z","timestamp":1497312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Acute parvovirus B19 (B19V) infection in immunocompromised patients may lead to severe anemia. However, in adult transplant recipients, B19V reactivations without anemia and low-level viremia are common. The impact of B19V in pediatric transplant patients, with high risk of primary infection, is investigated here. In a six-month period, 159 blood samples of 54 pediatric liver transplant recipients were tested for B19V DNA by quantitative real-time PCR. Viremia was correlated with anemia and immunosuppression and compared with rates in adult transplant recipients. B19V DNA was detected in 5\/54 patients. Primary B19V infections were observed in four patients prior to and in one patient after transplantation. Rates of viremia were significantly higher in pediatric recipients than in adults. Prolonged virus shedding after primary infection prior to transplantation accounts for most viremic cases. Anemia was significantly more frequent in samples from viremic patients, but remained mild. In 15% of anemic samples, B19V DNA was detected. Therefore, in anemic pediatric transplant recipients, diagnostics for B19V seem reasonable.<\/jats:p>","DOI":"10.3390\/v9060149","type":"journal-article","created":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T03:19:32Z","timestamp":1497410372000},"page":"149","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Impact of Parvovirus B19 Viremia in Liver Transplanted Children on Anemia: A Retrospective Study"],"prefix":"10.3390","volume":"9","author":[{"given":"Michael","family":"W\u00fcrdinger","sequence":"first","affiliation":[{"name":"Institute of Medical Microbiology and Hygiene, University of Regensburg, 93053 Regensburg, Germany"},{"name":"Department of Surgery and Transplantation, University Hospital of Zurich, 8091 Z\u00fcrich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Modrow","sequence":"additional","affiliation":[{"name":"Institute of Medical Microbiology and Hygiene, University of Regensburg, 93053 Regensburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annelie","family":"Plentz","sequence":"additional","affiliation":[{"name":"Institute of Medical Microbiology and Hygiene, University of Regensburg, 93053 Regensburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2017,6,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jcv.2004.05.015","article-title":"Long-term parvovirus B19 viremia associated with pure red cell aplasia after allogeneic bone marrow transplantation","volume":"31","author":"Plentz","year":"2004","journal-title":"J. Clin. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jmv.20251","article-title":"Recurrent high level parvovirus B19\/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3","volume":"75","author":"Liefeldt","year":"2005","journal-title":"J. Med. Virol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jcv.2012.04.023","article-title":"Human parvovirus B19 genotype 3 associated with chronic anemia after stem cell transplantation, missed by routine PCR testing","volume":"54","author":"Knoester","year":"2012","journal-title":"J. Clin. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jcv.2013.07.007","article-title":"Low-level DNAemia of parvovirus B19 (genotypes 1-3) in adult transplant recipients is not associated with anemia","volume":"58","author":"Plentz","year":"2013","journal-title":"J. Clin. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/jmv.23557","article-title":"Frequent occurrence of parvovirus B19 DNAemia in the first year after kidney transplantation","volume":"85","author":"Porignaux","year":"2013","journal-title":"J. Med. Virol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1017\/S0950268807009958","article-title":"Seroprevalence of parvovirus B19 in the German population","volume":"136","author":"Sauerbrei","year":"2008","journal-title":"Epidemiol. Infect."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1034\/j.1399-3046.2001.00035.x","article-title":"Parvovirus B19 infection in pediatric solid-organ and bone marrow transplantation","volume":"5","author":"Broliden","year":"2001","journal-title":"Pediatr. Transplant."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s100960000384","article-title":"Quantitative evidence for persistence of human parvovirus B19 DNA in an immunocompetent individual","volume":"19","author":"Cassinotti","year":"2000","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1128\/CMR.15.3.485-505.2002","article-title":"Human parvovirus B19","volume":"15","author":"Heegaard","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/infdis\/172.5.1360","article-title":"Parvovirus B19 clearance from peripheral blood after acute infection","volume":"172","author":"Musiani","year":"1995","journal-title":"J. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1128\/JCM.01201-09","article-title":"Phylogenetic analysis of human parvovirus B19 sequences from eleven different countries confirms the predominance of genotype 1 and suggests the spread of genotype 3b","volume":"47","author":"Mihneva","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1432-2277.2008.00818.x","article-title":"Clinical implications of quantitative real time-polymerase chain reaction of parvovirus B19 in kidney transplant recipients\u2014A prospective study","volume":"22","author":"Park","year":"2009","journal-title":"Transpl. Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/504812","article-title":"Parvovirus B19 infection after transplantation: A review of 98 cases","volume":"43","author":"Eid","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/jmv.21947","article-title":"Identification and characterization of acute infection with parvovirus B19 genotype 2 in immunocompromised patients in Poland","volume":"83","author":"Grabarczyk","year":"2011","journal-title":"J. Med. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1399-3062.2012.00773.x","article-title":"How many times can parvovirus B19-related anemia recur in solid organ transplant recipients?","volume":"14","author":"Gosset","year":"2012","journal-title":"Transpl. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1399-3046.2011.01631.x","article-title":"Risk factors for chronic anemia in pediatric orthotopic liver transplantation: analysis of data from the SPLIT registry","volume":"16","author":"Liem","year":"2012","journal-title":"Pediatr. Transplant."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/00007890-199310000-00011","article-title":"Parvovirus B19 infection in pediatric transplant patients","volume":"56","author":"Nour","year":"1993","journal-title":"Transplantation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ijantimicag.2010.11.027","article-title":"Immunoglobulin treatment in primary antibody deficiency","volume":"37","author":"Hoepelman","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s002280100305","article-title":"Pharmacokinetics of viral antibodies after administration of intravenous immunoglobulin in patients with chronic lymphocytic leukaemia or multiple myeloma","volume":"57","author":"Thurmann","year":"2001","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ejps.2009.02.014","article-title":"Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency","volume":"37","author":"Wasserman","year":"2009","journal-title":"European J. Pharm. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S0272-6386(99)70021-1","article-title":"Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus","volume":"34","author":"Wong","year":"1999","journal-title":"Am. J. Kidney Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"E76","DOI":"10.1111\/j.1399-3046.2010.01291.x","article-title":"Long-term remission of recurrent severe anemia as a result of parvovirus B19 infection in a pediatric renal transplant recipient","volume":"15","author":"Shen","year":"2011","journal-title":"Pediatr. Transplant."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1034\/j.1399-0012.2000.140612.x","article-title":"Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: A case report and review of literature","volume":"14","author":"Geetha","year":"2000","journal-title":"Clin. Transplant."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Haddad, E.M., McAlister, V.C., Renouf, E., Malthaner, R., Kjaer, M.S., and Gluud, L.L. (2006). Cyclosporin versus tacrolimus for liver transplanted patients. Cochrane Database Syst. Rev., CD005161.","DOI":"10.1002\/14651858.CD005161"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Webster, A., Woodroffe, R.C., Taylor, R.S., Chapman, J.R., and Craig, J.C. (2005). Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients. Cochrane Database Syst. Rev., CD003961.","DOI":"10.1002\/14651858.CD003961.pub2"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation","volume":"351","author":"Halloran","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1086\/514145","article-title":"Interrelationships among quantity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient serostatus, and administration of methylprednisolone as risk factors for HCMV disease following liver transplantation","volume":"176","author":"Cope","year":"1997","journal-title":"J. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/infdis\/152.2.257","article-title":"Experimental parvoviral infection in humans","volume":"152","author":"Anderson","year":"1985","journal-title":"J. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/thorax.55.7.619","article-title":"Anemia in lung transplant patient caused by parvovirus B19","volume":"55","author":"Kariyawasam","year":"2000","journal-title":"Thorax"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/ncpneph0609","article-title":"Parvovirus-B19-associated complications in renal transplant recipients","volume":"3","author":"Waldman","year":"2007","journal-title":"Nat. Clin. Pract. Nephrol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/9\/6\/149\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:38:54Z","timestamp":1760207934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/9\/6\/149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,13]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6]]}},"alternative-id":["v9060149"],"URL":"https:\/\/doi.org\/10.3390\/v9060149","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,13]]}}}